UniProt ID | ETS2_HUMAN | |
---|---|---|
UniProt AC | P15036 | |
Protein Name | Protein C-ets-2 | |
Gene Name | ETS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 469 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcription factor activating transcription. Binds specifically the DNA GGAA/T core motif (Ets-binding site or EBS) in gene promoters and stimulates transcription.. | |
Protein Sequence | MNDFGIKNMDQVAPVANSYRGTLKRQPAFDTFDGSLFAVFPSLNEEQTLQEVPTGLDSISHDSANCELPLLTPCSKAVMSQALKATFSGFKKEQRRLGIPKNPWLWSEQQVCQWLLWATNEFSLVNVNLQRFGMNGQMLCNLGKERFLELAPDFVGDILWEHLEQMIKENQEKTEDQYEENSHLTSVPHWINSNTLGFGTEQAPYGMQTQNYPKGGLLDSMCPASTPSVLSSEQEFQMFPKSRLSSVSVTYCSVSQDFPGSNLNLLTNNSGTPKDHDSPENGADSFESSDSLLQSWNSQSSLLDVQRVPSFESFEDDCSQSLCLNKPTMSFKDYIQERSDPVEQGKPVIPAAVLAGFTGSGPIQLWQFLLELLSDKSCQSFISWTGDGWEFKLADPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTSGKRYVYRFVCDLQNLLGFTPEELHAILGVQPDTED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Sumoylation | -MNDFGIKNMDQVAP -CCCCCCCCHHHHHH | 46.74 | - | |
7 | Ubiquitination | -MNDFGIKNMDQVAP -CCCCCCCCHHHHHH | 46.74 | - | |
7 | Sumoylation | -MNDFGIKNMDQVAP -CCCCCCCCHHHHHH | 46.74 | - | |
18 | Phosphorylation | QVAPVANSYRGTLKR HHHHCHHCCCCCCCC | 13.38 | 25159151 | |
19 | Phosphorylation | VAPVANSYRGTLKRQ HHHCHHCCCCCCCCC | 16.93 | 21712546 | |
22 | Phosphorylation | VANSYRGTLKRQPAF CHHCCCCCCCCCCCC | 21.80 | 25159151 | |
24 | Sumoylation | NSYRGTLKRQPAFDT HCCCCCCCCCCCCCC | 49.15 | - | |
24 | Sumoylation | NSYRGTLKRQPAFDT HCCCCCCCCCCCCCC | 49.15 | - | |
72 | Phosphorylation | NCELPLLTPCSKAVM CCCCCCCCCCCHHHH | 29.90 | 22128184 | |
80 | Phosphorylation | PCSKAVMSQALKATF CCCHHHHHHHHHHHH | 13.00 | 28555341 | |
84 | Sumoylation | AVMSQALKATFSGFK HHHHHHHHHHHCCHH | 48.69 | - | |
84 | Ubiquitination | AVMSQALKATFSGFK HHHHHHHHHHHCCHH | 48.69 | 29967540 | |
84 | Sumoylation | AVMSQALKATFSGFK HHHHHHHHHHHCCHH | 48.69 | - | |
88 | Phosphorylation | QALKATFSGFKKEQR HHHHHHHCCHHHHHH | 38.68 | 25159151 | |
91 | Ubiquitination | KATFSGFKKEQRRLG HHHHCCHHHHHHHHC | 59.95 | 29967540 | |
92 | Ubiquitination | ATFSGFKKEQRRLGI HHHCCHHHHHHHHCC | 57.74 | - | |
101 | Sumoylation | QRRLGIPKNPWLWSE HHHHCCCCCCCCCCH | 73.96 | - | |
144 | Ubiquitination | QMLCNLGKERFLELA CEEHHCCHHHHHHHC | 49.21 | 21987572 | |
173 | Ubiquitination | MIKENQEKTEDQYEE HHHHCHHHHHHHHHH | 47.66 | 29967540 | |
220 | Phosphorylation | PKGGLLDSMCPASTP CCCCCCCCCCCCCCC | 23.43 | 24218572 | |
224 | Ubiquitination | LLDSMCPASTPSVLS CCCCCCCCCCCCCCC | 22.55 | 29967540 | |
225 | Phosphorylation | LDSMCPASTPSVLSS CCCCCCCCCCCCCCC | 26.45 | 24218572 | |
226 | Phosphorylation | DSMCPASTPSVLSSE CCCCCCCCCCCCCCH | 22.99 | - | |
228 | Phosphorylation | MCPASTPSVLSSEQE CCCCCCCCCCCCHHH | 35.46 | - | |
231 | Ubiquitination | ASTPSVLSSEQEFQM CCCCCCCCCHHHHHC | 29.67 | 29967540 | |
241 | Ubiquitination | QEFQMFPKSRLSSVS HHHHCCCHHHCCCEE | 36.62 | 21963094 | |
246 | Phosphorylation | FPKSRLSSVSVTYCS CCHHHCCCEEEEEEE | 24.01 | 22817900 | |
248 | Phosphorylation | KSRLSSVSVTYCSVS HHHCCCEEEEEEEEC | 15.64 | - | |
255 | Phosphorylation | SVTYCSVSQDFPGSN EEEEEEECCCCCCCC | 14.03 | 25627689 | |
278 | Phosphorylation | GTPKDHDSPENGADS CCCCCCCCCCCCCCC | 30.60 | 24144214 | |
284 | Ubiquitination | DSPENGADSFESSDS CCCCCCCCCCCCCHH | 56.08 | 21987572 | |
285 | Phosphorylation | SPENGADSFESSDSL CCCCCCCCCCCCHHH | 30.31 | 24144214 | |
288 | Phosphorylation | NGADSFESSDSLLQS CCCCCCCCCHHHHHH | 37.12 | 24144214 | |
289 | Phosphorylation | GADSFESSDSLLQSW CCCCCCCCHHHHHHC | 24.83 | 24144214 | |
291 | Phosphorylation | DSFESSDSLLQSWNS CCCCCCHHHHHHCCC | 32.69 | 24144214 | |
295 | Phosphorylation | SSDSLLQSWNSQSSL CCHHHHHHCCCCCCC | 28.35 | 17192257 | |
298 | Phosphorylation | SLLQSWNSQSSLLDV HHHHHCCCCCCCCCC | 25.77 | 24719451 | |
300 | Phosphorylation | LQSWNSQSSLLDVQR HHHCCCCCCCCCCCC | 23.83 | 24144214 | |
301 | Phosphorylation | QSWNSQSSLLDVQRV HHCCCCCCCCCCCCC | 25.89 | 24144214 | |
310 | Phosphorylation | LDVQRVPSFESFEDD CCCCCCCCCHHCCCH | 38.50 | 26657352 | |
313 | Phosphorylation | QRVPSFESFEDDCSQ CCCCCCHHCCCHHHH | 31.74 | 20873877 | |
313 | Ubiquitination | QRVPSFESFEDDCSQ CCCCCCHHCCCHHHH | 31.74 | 29967540 | |
319 | Phosphorylation | ESFEDDCSQSLCLNK HHCCCHHHHHCCCCC | 29.78 | 20873877 | |
321 | Phosphorylation | FEDDCSQSLCLNKPT CCCHHHHHCCCCCCC | 12.54 | 20873877 | |
326 | Ubiquitination | SQSLCLNKPTMSFKD HHHCCCCCCCCCHHH | 28.99 | 21963094 | |
328 | Phosphorylation | SLCLNKPTMSFKDYI HCCCCCCCCCHHHHH | 27.36 | 20873877 | |
330 | Phosphorylation | CLNKPTMSFKDYIQE CCCCCCCCHHHHHHH | 31.46 | 20873877 | |
332 | Ubiquitination | NKPTMSFKDYIQERS CCCCCCHHHHHHHCC | 42.17 | 21963094 | |
381 | Ubiquitination | SDKSCQSFISWTGDG CCCCCHHHEECCCCC | 1.80 | 21963094 | |
392 | Sumoylation | TGDGWEFKLADPDEV CCCCEEEEECCHHHH | 31.11 | - | |
411 | Ubiquitination | GKRKNKPKMNYEKLS HHCCCCCCCCHHHHH | 41.19 | 24816145 | |
416 | Sumoylation | KPKMNYEKLSRGLRY CCCCCHHHHHHHHHH | 41.21 | - | |
416 | Ubiquitination | KPKMNYEKLSRGLRY CCCCCHHHHHHHHHH | 41.21 | 22505724 | |
416 | Sumoylation | KPKMNYEKLSRGLRY CCCCCHHHHHHHHHH | 41.21 | - | |
423 | Phosphorylation | KLSRGLRYYYDKNII HHHHHHHHEECCCEE | 16.06 | - | |
427 | Ubiquitination | GLRYYYDKNIIHKTS HHHHEECCCEEEECC | 33.65 | - | |
432 | Ubiquitination | YDKNIIHKTSGKRYV ECCCEEEECCCCCCE | 33.70 | 29967540 | |
466 | Ubiquitination | AILGVQPDTED---- HHHCCCCCCCC---- | 45.71 | 21963094 | |
472 | Ubiquitination | PDTED---------- CCCCC---------- | 21963094 | ||
551 | Ubiquitination | ----------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- | 24816145 | ||
556 | Ubiquitination | ---------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------- | 22505724 | ||
572 | Ubiquitination | -------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------- | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
72 | T | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
220 | S | Phosphorylation | Kinase | CDK10 | Q15131 | PSP |
225 | S | Phosphorylation | Kinase | CDK10 | Q15131 | PSP |
246 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
310 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
313 | S | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ETS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CDK10_HUMAN | CDK10 | physical | 11313931 | |
ZMY11_HUMAN | ZMYND11 | physical | 12894593 | |
FOS_HUMAN | FOS | physical | 9334186 | |
JUN_HUMAN | JUN | physical | 9334186 | |
ERG_HUMAN | ERG | physical | 9334186 | |
ETS1_HUMAN | ETS1 | physical | 9334186 | |
CBP_HUMAN | CREBBP | physical | 15572696 | |
EP300_HUMAN | EP300 | physical | 15572696 | |
CBP_HUMAN | CREBBP | physical | 10358095 | |
EP300_HUMAN | EP300 | physical | 10358095 | |
CBP_HUMAN | CREBBP | physical | 14722092 | |
EP300_HUMAN | EP300 | physical | 14722092 | |
P53_HUMAN | TP53 | physical | 18374905 | |
XPO1_HUMAN | XPO1 | physical | 12860972 | |
SRA1_HUMAN | SRA1 | physical | 20398657 | |
TWST1_HUMAN | TWIST1 | physical | 18598946 | |
TWST2_HUMAN | TWIST2 | physical | 18598946 | |
RFWD2_HUMAN | RFWD2 | physical | 25117710 | |
VPS51_HUMAN | VPS51 | physical | 26496610 | |
CTDP1_HUMAN | CTDP1 | physical | 26496610 | |
TF3C5_HUMAN | GTF3C5 | physical | 26496610 | |
IMPCT_HUMAN | IMPACT | physical | 26496610 | |
RFWD2_HUMAN | RFWD2 | physical | 26496610 | |
RM14_HUMAN | MRPL14 | physical | 26496610 | |
ANKS6_HUMAN | ANKS6 | physical | 26496610 | |
RFWD2_HUMAN | RFWD2 | physical | 26871468 | |
DET1_HUMAN | DET1 | physical | 26871468 | |
P53_HUMAN | TP53 | physical | 26871468 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295, AND MASSSPECTROMETRY. |